Cedars Sinai
- 18th Annual Women and Ischemic Heart Disease Symposium
- 24th Annual Educational Meeting in Gastroenterology
- 12th Annual New Therapeutics in Oncology: The Road to Personalized Medicine
- The IX Cedars-Sinai Parkinson's Disease and Movement Disorders Annual Symposium
- 17th Annual Women and Ischemic Heart Disease Symposium
- 23rd Annual Educational Meeting in Gastroenterology
- Latest Updates on Neuroimmunology
- Practicum in Mechanical Circulatory Support (MCS): Managing Cardiogenic Shock with Short-Term Devices
- 2022 Pediatric State of The Art Conference: Expanding the Horizons of Pediatric Care
- 16th Annual Women and Ischemic Heart Disease Symposium
- The 13th Annual Symposium on Neurovascular Disease: Symptoms and Solutions
- Controversies and Advances in the Treatment of Cardiovascular Disease: The Twentieth in the Series
- 21st Annual Educational Meeting in Gastroenterology
- 15th Annual Women and Ischemic Heart Disease Symposium
- 22nd Annual Educational Meeting in Gastroenterology
- 8th Annual Cedars-Sinai Update in Obstetrics & Gynecology Conference
- Videos
- Events
Playback speed
10 seconds
ASCO® 2024 Insights: "EMBARK Study - Impact of Treatment Suspension on HRQoL in High-Risk BCR nmHSPC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Stephen Freedland
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Stephen Freedland
0 views
June 13, 2024
Chapters
EMBARK Study & Sponsorship Disclosure
00:00
Treatment Suspension & HRQoL Impact
01:30
Quality of Life & Treatment Outcomes
03:20
Comments 0
Login to view comments.
Click here to Login
Videos